This precancerous condition can progress to active multiple myeloma, a type of blood cancer. High-risk ... Multiple Myeloma: Cilta-Cel Found Highly Effective in Real-World Study Oct. 4 ...
A team of researchers has developed a new biomaterial with high potential in in the treatment of bone lesions or minimal residual disease in multiple myeloma patients. The findings showcase a ...
The expert knowledge presented at this year’s International Myeloma Society (IMS) annual meeting focused on minimal residual disease testing and status, defining and treating high-risk disease ...